Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

A simple wound rinse might cut Post-Surgery bleeding

NCT ID NCT06270407

Disease control Sponsor: St. Olavs Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 14, 2026 · Last updated Aug 14, 2026

Summary

This trial tests whether applying tranexamic acid (TXA) directly to the wound surface at the end of plastic surgery can reduce complications like re-bleeding, infection, or wound breakdown. About 3,000 adults having plastic surgery will receive either TXA or a saline placebo in a double-blind setup, meaning neither they nor their doctors know which they got. The main goal is to see if TXA lowers the need for interventions to stop bleeding within the first 10 days after surgery, while also checking for any increased risk of blood clots.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
tranexamic acid applied directly to the wound surface
What this could lead to
If it works, this simple, low-cost approach could reduce bleeding and wound complications after plastic surgery, improving recovery and safety.
What could go wrong
The trial is still testing the idea, and results may not show a clear benefit. There is also a theoretical concern about increased blood clot risk, which the study will monitor.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

About 3,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2024

Expected to finish

Dec 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients are eligible to be included in the study only if all of the following criteria apply: 1. They are to undergo a surgical procedure within the field of plastic surgery where the procedure involves use of topical TXA at the participating center. 2. They are over 18 years of age and capable of independently providing informed consent 3. They have received adequate oral and written information about the study and signed the informed-consent form Exclusion Criteria: * Patients with known allergy to tranexamic acid.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Surgical complication are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Surgical complication

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    11 sites in 3 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Bærum Sykehus

    RECRUITING

    Gjettum, 1346, Norway

  • Haraldsplass Diakonale Sykehus

    RECRUITING

    Bergen, 5009, Norway

  • Helsinki University Hospital HUS

    RECRUITING

    Helsinki, 00029, Finland

  • Oslo Universitetssykehus Rikshospitalet

    RECRUITING

    Oslo, 0372, Norway

  • St Olav's University Hospital

    RECRUITING

    Trondheim, 7006, Norway

  • Stavanger Universitetssykehus SUS

    NOT_YET_RECRUITING

    Stavanger, 4017, Norway

  • Sykehuset Innlandet Hamar

    NOT_YET_RECRUITING

    Hamar, 2318, Norway

  • Sykehuset Innlandet Tynset

    RECRUITING

    Tynset, 2500, Norway

  • Sykehuset Nordmøre og Romsdal

    RECRUITING

    Hjelset, 6450, Norway

  • UNN Tromsø

    RECRUITING

    Tromsø, 9019, Norway

  • Vejle Sykehus

    RECRUITING

    Vejle, 7100, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.